The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial-Reference-Cited by-同舟云学术

The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial

Published:2023-10 Issue: Volume: Page:
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Dart John K.G.^ORCID,Papa Vincenzo^ORCID,Rama Paolo,Knutsson Karl Anders^ORCID,Ahmad Saj,Hau Scott,Sanchez Sara,Franch Antonella,Birattari Federica,Leon Pia,Fasolo Adriano^ORCID,Kominek Ewa Mrukwa,Jadczyk-Sorek Katarzyna^ORCID,Carley Fiona,Hossain Parwez,Minassian Darwin C.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference14 articles.

1. Acanthamoeba keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases;Papa;Br J Ophthalmol,2020

2. The rising incidence of Acanthamoeba keratitis: a 7-year nationwide survey and clinical assessment of risk factors and functional outcomes;Randag;PLoS One,2019

3. Advances in the management of Acanthamoeba keratitis: a review of the literature and synthesized algorithmic approach;Kaufman;Ocul Surf,2022

4. Acanthamoeba keratitis risk factors for daily wear contact lens users: a case-control study;Carnt;Ophthalmology,2023

5. Acanthamoeba keratitis in South India: a longitudinal analysis of epidemics;Lalitha;Ophthalmic Epidemiol,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The incidence of severe complications in acanthamoeba keratitis: Qualitative and quantitative systematic assessment;Survey of Ophthalmology;2024-09

2. Rethinking Keratoplasty for Patients with Acanthamoeba Keratitis: Early “Low Load Keratoplasty” in Contrast to Late Optical and Therapeutic Keratoplasty;Microorganisms;2024-08-30

3. Ouabain, ATPase inhibitor, potentially enhances the effect of polyhexamethylene biguanide on Acanthamoeba castellanii;International Journal for Parasitology: Drugs and Drug Resistance;2024-08

4. Enhancing Rose Bengal penetration in ex vivo human corneas using iontophoresis;Therapeutic Delivery;2024-07-18

5. Acanthamoeba keratitis: new hopes for potential interventions for a curable but often refractory disease;Expert Review of Ophthalmology;2024-06-24